RICHARD WYNN: Open Payments
NPI 1356365480 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,586 in 89 payments from 22 companies in 2025. Trend: 2023 $2,391 · 2024 $1,967 · 2025 $1,586
Food & beverage: $1,586
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 18 | $354 |
| Gilead Sciences, Inc. | 17 | $229 |
| Amgen Inc. | 8 | $206 |
| PFIZER INC. | 10 | $158 |
| ABBVIE INC. | 9 | $139 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Astellas Pharma US Inc | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Abbott Laboratories | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
Products named: NURTEC ODT, DOVATO, CABENUVA, VRAYLAR, APRETUDE, OTEZLA, COBENFY, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
